All patients included in the study were positive for ANAs and we observed significant negative correlations between serum complement C3 and C4 levels and anti-dsDNA and anti-snRNP autoantibodies, respectively (online resource 1), in the sera of SLE patients. The gene discussed is LSM2; the disease is systemic lupus erythematosus.